Regeneron Pharmaceuticals, Inc.
Maytansinoid derivatives, conjugates thereof, and methods of use
Last updated:
Abstract:
Provided herein are maytansinoid compounds, derivatives thereof, conjugates thereof, and methods of treating or preventing proliferative diseases with the same.
Status:
Grant
Type:
Utility
Filling date:
24 Oct 2019
Issue date:
20 Sep 2022